Figure 2.
Screening of core targets for FXF in the treatment of pulmonary fibrosis. (a) As observed from the Venn diagram, there were 87 overlapping candidate targets between FXF and the known targets associated with pathological course in pulmonary fibrosis. (b) The candidate component-target network for FXF in the treatment of pulmonary fibrosis. (c) The core component-target network for FXF in the treatment of pulmonary fibrosis.